OPHTESIA

This brand name is authorized in Croatia

Active ingredients

The drug OPHTESIA contains one active pharmaceutical ingredient (API):

1 Oxybuprocaine UNII 0VE4U49K15 - BENOXINATE HYDROCHLORIDE
Read about Oxybuprocaine

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
S01HA02	Oxybuprocaine	S Sensory organs → S01 Ophthalmologicals → S01H Local anesthetics → S01HA Local anesthetics
Discover more medicines within S01HA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: HR	Agencija za lijekove i medicinske proizvode	Identifier(s): HR-H-307087715

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.